![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Safety & Efficacy of Raltegravir in Patients Co-infected with HIV and Hepatitis B and/or C Virus: Complete Data from Phase III Double-Blind Studies
|
|
|
Reported by Jules Levin
Glasgow Nov 11-15 2012
Jürgen Kurt Rockstroh1, Peter Sklar2, Hong Wan2,
Hedy Teppler2, Anthony Rodgers2, Charlotte Harvey2,
Kim Strohmaier2, Randi Leavitt2, Bach-Yen Nguyen2
1University of Bonn, Bonn-Venusberg, Germany
2Merck Sharp & Dohme Corp., Whitehouse Station, NJ
![Glasgow1.gif](../images/111612/111612-7/Glasgow1.gif)
![Glasgow2.gif](../images/111612/111612-7/Glasgow2.gif)
![Glasgow3.gif](../images/111612/111612-7/Glasgow3.gif)
![Glasgow4.gif](../images/111612/111612-7/Glasgow4.gif)
![Glasgow5.gif](../images/111612/111612-7/Glasgow5.gif)
![Glasgow6.gif](../images/111612/111612-7/Glasgow6.gif)
![Glasgow7.gif](../images/111612/111612-7/Glasgow7.gif)
![Glasgow8.gif](../images/111612/111612-7/Glasgow8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|